Related Experiment Video
Updated: Jun 29, 2026

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA
Xinyue Ren1,2, Ying Yang1,2,3, Min Wang1
1State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Abstract:
DNA methylation and demethylation are key epigenetic events that regulate gene expression and cell fate. DNA demethylation via oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) is typically mediated by TET (ten-eleven translocation) enzymes. The 5hmC modification is considered an intermediate state of DNA demethylation; it is particularly prevalent in the brain and is believed to play a role in the development of many cell types in the brain. Our previous studies have identified that vitamin C (Vc) and MEK inhibitor PD0325901 could significantly promote OPC (oligodendrocyte progenitor cell)-to-OL (oligodendrocyte) differentiation. Here we discovered that Vc and PD0325901 may promote OPC-to-OL differentiation by inducing DNA demethylation via hydroxymethylation. Blocking 5hmC formation almost totally blocked Vc- and PD0325901-stimulated OPC-to-OL differentiation. In addition, TET1 is not involved in Vc,- and PD0325901-promoted OL generation. We also found a synergistic effect between the two compounds in inducing OL generation, suggesting the possibility of a combination therapy for demyelination diseases in the future.
Insights
Vitamin C and a MEK inhibitor promote oligodendrocyte differentiation by increasing 5-hydroxymethylcytosine (5hmC) DNA demethylation. This epigenetic modification is crucial for cell fate and holds potential for treating demyelination diseases.
Area of Science:
- Epigenetics
- Neuroscience
- Cell Biology
Background:
- DNA methylation and demethylation are critical epigenetic mechanisms governing gene expression and cell differentiation.
- 5-hydroxymethylcytosine (5hmC) is a key intermediate in DNA demethylation, particularly important in brain development.
- Oligodendrocyte progenitor cells (OPCs) differentiate into oligodendrocytes (OLs), essential for myelin sheath formation in the central nervous system.
Purpose of the Study:
- To investigate the role of DNA demethylation via hydroxymethylation in Vitamin C (Vc) and MEK inhibitor PD0325901-induced OPC-to-OL differentiation.
- To determine if TET1 is involved in the differentiation process promoted by Vc and PD0325901.
- To explore the potential of Vc and PD0325901 as a combination therapy for demyelination diseases.
Main Methods:
- Treatment of OPCs with Vitamin C (Vc) and MEK inhibitor PD0325901.
- Assessment of OPC-to-OL differentiation.
- Inhibition of 5hmC formation to evaluate its role in Vc- and PD0325901-stimulated differentiation.
- Analysis of TET1 involvement in the differentiation process.
Main Results:
- Vc and PD0325901 significantly promote OPC-to-OL differentiation.
- This promotion is mediated by inducing DNA demethylation through hydroxymethylation (5hmC).
- Blocking 5hmC formation abrogated the differentiation-promoting effects of Vc and PD0325901.
- TET1 was found not to be involved in the Vc- and PD0325901-promoted OL generation.
- A synergistic effect was observed between Vc and PD0325901 in inducing OL generation.
Conclusions:
- Vitamin C and PD0325901 enhance OPC-to-OL differentiation by increasing 5hmC levels, indicating a role for DNA hydroxymethylation in this process.
- The findings suggest that TET1 is not the primary mediator of this effect.
- The synergistic action of Vc and PD0325901 presents a promising therapeutic strategy for demyelination disorders.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

